These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7696105)

  • 21. Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity).
    Sivan B; Lilos P; Laron Z
    J Pediatr Endocrinol Metab; 2003; 16(4):509-20. PubMed ID: 12793602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome.
    Brat O; Ziv I; Klinger B; Avraham M; Laron Z
    Horm Res; 1997; 47(2):45-8. PubMed ID: 9030966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination.
    Hazel SJ; Gillespie CM; Moore RJ; Clark RG; Jureidini KF; Martin AA
    Kidney Int; 1994 Jul; 46(1):58-68. PubMed ID: 7933849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.
    Gill MS; Whatmore AJ; Tillman V; White A; Addison GM; Price DA; Clayton PE
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):483-92. PubMed ID: 9196612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of human recombinant insulin-like growth factor-I in critically ill patients.
    Yarwood GD; Ross RJ; Medbak S; Coakley J; Hinds CJ
    Crit Care Med; 1997 Aug; 25(8):1352-61. PubMed ID: 9267949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery.
    Miell JP; Taylor AM; Jones J; Buchanan CR; Rennie J; Sherwood R; Leicester R; Ross RJ
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):542-51. PubMed ID: 1283730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome.
    Klinger B; Anin S; Silbergeld A; Eshet R; Laron Z
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):81-7. PubMed ID: 9509072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal and electrolyte effects of total parenteral nutrition.
    Batuman V; Dreisbach A; Maesaka JK; Rothkopf M; Ross E
    JPEN J Parenter Enteral Nutr; 1984; 8(5):546-51. PubMed ID: 6436529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of IGF-I on renal function in end-stage chronic renal failure.
    Miller SB; Moulton M; O'Shea M; Hammerman MR
    Kidney Int; 1994 Jul; 46(1):201-7. PubMed ID: 7933838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of insulin-like growth factor-I peptides in rats with acute renal failure.
    Martin AA; Gillespie CM; Moore L; Ballard FJ; Read LC
    J Endocrinol; 1994 Jan; 140(1):23-32. PubMed ID: 8138750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low dose of recombinant human growth hormone on renal excretion of insulin-like growth factor-I (IGF-I) in humans: an inverse relation between serum and urinary IGF-I level.
    Uemasu J; Fujihara M; Kawasaki H
    Clin Nephrol; 1996 Jul; 46(1):1-5. PubMed ID: 8832140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of growth hormone therapy on bone metabolism of growth hormone deficient children.
    Stamoyannou L; Karachaliou F; Gioureli E; Voskaki E; Mengreli C; Bartsocas CS; Koutselinis A
    Eur J Pediatr; 1997 Aug; 156(8):592-6. PubMed ID: 9266187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.
    Ding H; Kopple JD; Cohen A; Hirschberg R
    J Clin Invest; 1993 May; 91(5):2281-7. PubMed ID: 8486787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum ghrelin concentrations are increased in children with growth hormone insensitivity and decrease during long-term insulinlike growth factor-I treatment.
    Uckun-Kitapci A; Haqq AM; Purnell JQ; Newcomb K; Gulkesen H; Underwood LE
    J Investig Med; 2008 Jan; 56(1):26-31. PubMed ID: 18317425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.